Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys

References

• Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, et al. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22:115-20; PMID:11788470; http://dx.doi.org/10.1161/hq0102.102278
   PubMed Web of Science ®Google Scholar
• Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000; 192:1075-80; PMID:11015448; http://dx.doi.org/10.1084/jem.192.7.1075
   PubMed Web of Science ®Google Scholar
• Shahrara S, Proudfoot AE, Park CC, Volin MV, Haines GK, Woods JM, Aikens CH, Handel TM, Pope RM. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol 2008; 180:3447-56; PMID:18292571; http://dx.doi.org/10.4049/jimmunol.180.5.3447
   PubMed Web of Science ®Google Scholar
• Moore BB, Paine R, 3rd, Christensen PJ, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, Toews GB. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 2001; 167:4368-77; PMID:11591761; http://dx.doi.org/10.4049/jimmunol.167.8.4368
   PubMed Web of Science ®Google Scholar
• Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005; 4:619-25; PMID:17305518; http://dx.doi.org/10.2174/156801005774912806
   PubMedGoogle Scholar
• Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71:257-66; PMID:9139852; http://dx.doi.org/10.1002/(SICI)1097-0215(19970410)71:2%3c257::AID-IJC22%3e3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89:462-73; PMID:12761880; http://dx.doi.org/10.1002/jcb.10522
   PubMed Web of Science ®Google Scholar
• Vanderkerken K, Vande Broek I, Eizirik DL, Van Valckenborgh E, Asosingh K, Van Riet I, Van Camp B. Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells. Clin Exp Metastasis 2002; 19:87-90; PMID:11918087; http://dx.doi.org/10.1023/A:1013891205989
   PubMed Web of Science ®Google Scholar
• Bai Z, Hayasaka H, Kobayashi M, Li W, Guo Z, Jang MH, Kondo A, Choi BI, Iwakura Y, Miyasaka M. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J Immunol 2009; 182:1287-95; PMID:19155474; http://dx.doi.org/10.4049/jimmunol.182.3.1287
   PubMed Web of Science ®Google Scholar
• Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8:362-71; PMID:18379575; http://dx.doi.org/10.1038/nri2297
   PubMed Web of Science ®Google Scholar
• Choi ES, Pierce EM, Jakubzick C, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Moore BB, Toews GB, et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J Clin Pathol 2006; 59:28-39; PMID:16394278; http://dx.doi.org/10.1136/jcp.2005.026872
   PubMed Web of Science ®Google Scholar
• Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Evanoff H, Flaherty KR, Martinez FJ, Toews GB, Hogaboam CM. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 2007; 29:1082-93; PMID:17331965; http://dx.doi.org/10.1183/09031936.00122806
   PubMed Web of Science ®Google Scholar
• Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Flaherty KR, Martinez FJ, Hogaboam CM. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. Am J Pathol 2007; 170:1152-64; PMID:17392156; http://dx.doi.org/10.2353/ajpath.2007.060649
   PubMed Web of Science ®Google Scholar
• Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH, et al. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. J Pharm Sci 1992; 81:605-10; PMID:1355792; http://dx.doi.org/10.1002/jps.2600810630
   PubMed Web of Science ®Google Scholar
• Vugmeyster Y, Harrold J, Xu X. Absorption, distribution, metabolism, and excretion (ADME) studies of biotherapeutics for autoimmune and inflammatory conditions. Aaps J 2012; 14:714-27; PMID:22798020; http://dx.doi.org/10.1208/s12248-012-9385-y
   PubMed Web of Science ®Google Scholar
• Xu X, Vugmeyster Y. Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of therapeutic biologics. Aaps J 2012; 14:781-91; PMID:22864668; http://dx.doi.org/10.1208/s12248-012-9388-8
   PubMed Web of Science ®Google Scholar
• Comerford I, Nibbs RJ, Litchfield W, Bunting M, Harata-Lee Y, Haylock-Jacobs S, Forrow S, Korner H, McColl SR. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 2010; 116:4130-40; PMID:20562329; http://dx.doi.org/10.1182/blood-2010-01-264390
   PubMed Web of Science ®Google Scholar
• Nureki S, Miyazaki E, Ishi T, Ito T, Takenaka R, Ando M, Kumamoto T. Elevated concentrations of CCR7 ligands in patients with eosinophilic pneumonia. Allergy 2013; 68:1387-95; PMID:24111618; http://dx.doi.org/10.1111/all.12243
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21; PMID:16467548; http://dx.doi.org/10.1056/NEJMra052723
   PubMed Web of Science ®Google Scholar
• Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2:108-15; PMID:11175802; http://dx.doi.org/10.1038/84209
   PubMed Web of Science ®Google Scholar
• Harada K, Nakanuma Y. Innate immunity in the pathogenesis of cholangiopathy: a recent update. Inflamm Allergy Drug Targets 2012; 11:478-83; PMID:22920631; http://dx.doi.org/10.2174/187152812803589976
   PubMedGoogle Scholar
• Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 2009; 15:2962-70; PMID:19383822; http://dx.doi.org/10.1158/1078-0432.CCR-08-2495
   PubMed Web of Science ®Google Scholar
• Igawa T, Mimoto F, Hattori K. pH-dependent antigen-binding antibodies as a novel therapeutic modality. Biochim Biophys Acta 2014; 1844:1943-50; PMID:25125373; http://dx.doi.org/10.1016/j.bbapap.2014.08.003
   PubMed Web of Science ®Google Scholar
• Igawa T, Ishii S, Tachibana T, Maeda A, Higuchi Y, Shimaoka S, Moriyama C, Watanabe T, Takubo R, Doi Y, et al. Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat Biotechnol 2010; 28:1203-7; PMID:20953198; http://dx.doi.org/10.1038/nbt.1691
   PubMed Web of Science ®Google Scholar
• Chaparro-Riggers J, Liang H, DeVay RM, Bai L, Sutton JE, Chen W, Geng T, Lindquist K, Casas MG, Boustany LM, et al. Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9. J Biol Chem 2012; 287:11090-7; PMID:22294692; http://dx.doi.org/10.1074/jbc.M111.319764
   PubMed Web of Science ®Google Scholar
• Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, et al. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54:2387-92; PMID:16869001; http://dx.doi.org/10.1002/art.21975
   PubMed Web of Science ®Google Scholar
• Deng R, Iyer S, Theil FP, Mortensen DL, Fielder PJ, Prabhu S. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? MAbs 2011; 3:61-6; PMID:20962582; http://dx.doi.org/10.4161/mabs.3.1.13799
   PubMed Web of Science ®Google Scholar
• Xiao JJ, Krzyzanski W, Wang YM, Li H, Rose MJ, Ma M, Wu Y, Hinkle B, Perez-Ruixo JJ. Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys. Aaps J 2010; 12:646-57; PMID:20737261; http://dx.doi.org/10.1208/s12248-010-9222-0
   PubMed Web of Science ®Google Scholar
• Fetterly GJ, Aras U, Meholick PD, Takimoto C, Seetharam S, McIntosh T, de Bono JS, Sandhu SK, Tolcher A, Davis HM, et al. Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. J Clin Pharmacol 2013; 53:1020-7; PMID:23878055; http://dx.doi.org/10.1002/jcph.140
   PubMed Web of Science ®Google Scholar
• Sandhu SK, Papadopoulos K, Fong PC, Patnaik A, Messiou C, Olmos D, Wang G, Tromp BJ, Puchalski TA, Balkwill F, et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharmacol 2013; 71:1041-50; PMID:23385782; http://dx.doi.org/10.1007/s00280-013-2099-8
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Tannenbaum S, Rordorf C, Lowe PJ, Floch D, Gram H, Roy S. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1beta monoclonal antibody. Clin Pharmacokinet 2012; 51:e1-18; PMID:22550964; http://dx.doi.org/10.2165/11599820-000000000-00000
   PubMedGoogle Scholar
• Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, Wittkowski H, Bek S, Hartmann N, Bosset S, et al. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med 2009; 206:1029-36; PMID:19364880; http://dx.doi.org/10.1084/jem.20082481
   PubMed Web of Science ®Google Scholar
• Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005; 106:444-6; PMID:15863780; http://dx.doi.org/10.1182/blood-2004-11-4353
   PubMed Web of Science ®Google Scholar